Alpha-Siro
Sirolimus Stent

Sirolimus Eluting Coronary Stent System (Drug Eluting Stent)

Alpha-Siro
Alpha-Siro

  • L 605 cobalt-chromium stent platform with open and closed cell design
  • Unique stent design and strut locking mechanism offers excellent radial strength and minimum recoil
  • Uniform neointimal coverage and improved stent apposition
  • Completely biodegradable, biocompatible polymer (PLGA carrier) - Loading density of 1.35 μ/mm2
  • Uniform coating thickness with precisely programmed release kinetics
  • Complete endothelialisation within 90 days
  • 90% of sirolimus released within 90 to 120 days
  • Inhibits In-stent restenosis (ISR) & late stent thrombosis with adequate re-endothelization
  • Designed for utmost safety - Premier displays one of the lowest entry profiles
  • Hydrophilic coated stent delivery system